PapersFlow Research Brief
Genetics and Neurodevelopmental Disorders
Research Guide
What is Genetics and Neurodevelopmental Disorders?
Genetics and Neurodevelopmental Disorders is a research cluster examining the molecular basis, genetic mutations, and neurological manifestations of Rett syndrome and related conditions such as Fragile X syndrome, with focus on MeCP2, synaptic function, autism-like behaviors, and altered brain development.
This field has produced 55,741 works on genetic factors in neurodevelopmental disorders including Rett syndrome and Fragile X syndrome. Research centers on MeCP2's role, synaptic function disruptions, and brain development changes linked to autism-like behaviors. Key investigations involve epigenetic regulation of GABAergic neurotransmission relevant to these disorders, as shown in studies with thousands of citations.
Topic Hierarchy
Research Sub-Topics
MeCP2 Mutations in Rett Syndrome
Researchers characterize genetic variants in MECP2, their functional impacts on transcription regulation, and genotype-phenotype correlations in Rett patients. Studies include mutation screening and modeling.
Synaptic Dysfunction in Fragile X Syndrome
This area investigates FMRP loss effects on synapse maturation, plasticity, and connectivity using animal models and human iPSCs. Research targets mGluR-dependent long-term depression.
Epigenetic Dysregulation in Neurodevelopmental Disorders
Scholars study aberrant DNA methylation and histone modifications mediated by MeCP2 in Rett and related syndromes. Work explores reversibility and pharmacological epigenetics.
Dendritic Spine Abnormalities in Autism Models
Studies quantify spine density, morphology, and dynamics in Fragile X and Rett mouse models, linking to behavioral deficits. High-resolution imaging tracks developmental trajectories.
mGluR Theory of Fragile X Syndrome
Researchers test the hypothesis that excessive mGluR signaling causes core phenotypes, validating negative allosteric modulators in preclinical trials. Work extends to other disorders.
Why It Matters
Research in genetics and neurodevelopmental disorders identifies specific genetic mutations driving conditions like Rett syndrome and Fragile X syndrome, informing potential therapies targeting MeCP2 and synaptic function. For instance, Shrestha and Offer (2016) in "Epigenetic Regulations of GABAergic Neurotransmission: Relevance for Neurological Disorders and Epigenetic Therapy" highlight how epigenetic changes in GABAergic systems contribute to neurological disorders, suggesting avenues for epigenetic therapy with 8,954 citations. Bird (2002) in "DNA methylation patterns and epigenetic memory" explains how DNA methylation establishes cell identity, directly relevant to neurodevelopmental pathologies involving improper gene expression patterns, cited 6,986 times. These insights support diagnostics like the Autism-Spectrum Quotient from Baron-Cohen et al. (2001), used in assessing autism spectrum traits, and enable genetic mapping techniques from Botstein et al. (1980), foundational for locating disorder-linked polymorphisms.
Reading Guide
Where to Start
"Epigenetic Regulations of GABAergic Neurotransmission: Relevance for Neurological Disorders and Epigenetic Therapy" by Shrestha and Offer (2016) is the starting point for beginners, as it directly connects epigenetic mechanisms to neurodevelopmental disorders like those in Rett and Fragile X syndromes with clear relevance to therapy.
Key Papers Explained
Shrestha and Offer (2016) "Epigenetic Regulations of GABAergic Neurotransmission: Relevance for Neurological Disorders and Epigenetic Therapy" builds on foundational epigenetic principles from Bird (2002) "DNA methylation patterns and epigenetic memory" and Jaenisch and Bird (2003) "Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals," applying them to GABAergic systems in neurodevelopmental disorders. Botstein et al. (1980) "Construction of a genetic linkage map in man using restriction fragment length polymorphisms" provides the genetic mapping basis for identifying mutations discussed in these works. Lord et al. (2000) "The Autism Diagnostic Observation Schedule—Generic" and Baron-Cohen et al. (2001) "The Autism-Spectrum Quotient (AQ)" offer diagnostic validation for synaptic and behavioral phenotypes emerging from such genetic insights.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Current frontiers emphasize synaptic function and mGluR theory applications in Fragile X models, alongside MeCP2's role in Rett syndrome epigenetics. No recent preprints or news from the last 12 months are available, so focus remains on established high-citation works like Shrestha and Offer (2016) for therapeutic epigenetics targeting brain development alterations.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Genome-wide association study of 14,000 cases of seven common ... | 2007 | Nature | 9.6K | ✓ |
| 2 | Epigenetic Regulations of GABAergic Neurotransmission: Relevan... | 2016 | Medical Epigenetics | 9.0K | ✓ |
| 3 | Construction of a genetic linkage map in man using restriction... | 1980 | PubMed | 8.4K | ✕ |
| 4 | A novel gene containing a trinucleotide repeat that is expande... | 1993 | Cell | 8.3K | ✓ |
| 5 | The Autism Diagnostic Observation Schedule—Generic: A Standard... | 2000 | Journal of Autism and ... | 7.5K | ✕ |
| 6 | DNA methylation patterns and epigenetic memory | 2002 | Genes & Development | 7.0K | ✓ |
| 7 | The Autism-Spectrum Quotient (AQ): Evidence from Asperger Synd... | 2001 | Journal of Autism and ... | 6.2K | ✕ |
| 8 | Epigenetic regulation of gene expression: how the genome integ... | 2003 | Nature Genetics | 6.2K | ✕ |
| 9 | Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in M... | 2009 | Science | 5.7K | ✓ |
| 10 | Mutations in the parkin gene cause autosomal recessive juvenil... | 1998 | Nature | 5.2K | ✕ |
Frequently Asked Questions
What role does MeCP2 play in neurodevelopmental disorders?
MeCP2 is central to Rett syndrome and related neurodevelopmental disorders, influencing synaptic function and brain development. Disruptions lead to autism-like behaviors and neurological manifestations. This cluster highlights its molecular basis in genetic mutations.
How do epigenetic mechanisms contribute to these disorders?
Epigenetic regulations, such as DNA methylation, control gene expression in GABAergic neurotransmission relevant to neurodevelopmental disorders. Shrestha and Offer (2016) showed these mechanisms affect neurogenesis and central nervous system development. Therapies targeting epigenetics are proposed based on such patterns.
What is the mGluR theory in Fragile X syndrome?
The mGluR theory addresses synaptic dysfunction in Fragile X syndrome, linking metabotropic glutamate receptor signaling to altered dendritic spines. It explains autism-like behaviors through genetic mutations. Research in this cluster explores its implications for brain development.
How are genetic linkage maps used in studying these disorders?
Botstein et al. (1980) in "Construction of a genetic linkage map in man using restriction fragment length polymorphisms" introduced methods to map human genome polymorphisms. These detect mutations in disorders like Rett and Fragile X syndromes. The approach has 8,380 citations and supports identifying disease loci.
What diagnostic tools assess autism spectrum deficits?
Lord et al. (2000) developed "The Autism Diagnostic Observation Schedule—Generic: A Standard Measure of Social and Communication Deficits Associated with the Spectrum of Autism," standardizing evaluation of social and communication issues. Baron-Cohen et al. (2001) introduced "The Autism-Spectrum Quotient (AQ)" for high-functioning autism and Asperger syndrome traits. Both tools, with over 6,000 citations each, aid clinical and research applications.
What is the current state of research volume?
The field encompasses 55,741 works focused on genetics of Rett syndrome, Fragile X, and related disorders. Growth data over five years is unavailable. Top papers exceed 5,000 citations, indicating established impact.
Open Research Questions
- ? How do specific MeCP2 mutations differentially affect synaptic function in Rett syndrome models?
- ? What epigenetic modifiers can reverse GABAergic neurotransmission deficits in Fragile X syndrome?
- ? Which genetic interactions between trinucleotide repeats and environmental factors exacerbate neurodevelopmental outcomes?
- ? How do DNA methylation patterns influence dendritic spine morphology in autism-like behaviors?
- ? What undiscovered polymorphisms link parkin mutations to neurodevelopmental rather than purely neurodegenerative phenotypes?
Recent Trends
The field maintains 55,741 works with no specified five-year growth rate.
Citation leaders like "Epigenetic Regulations of GABAergic Neurotransmission: Relevance for Neurological Disorders and Epigenetic Therapy" by Shrestha and Offer at 8,954 citations underscore sustained focus on epigenetics in disorders involving MeCP2 and synaptic function.
2016No recent preprints or news coverage from the last six to twelve months indicate steady rather than rapidly expanding activity.
Research Genetics and Neurodevelopmental Disorders with AI
PapersFlow provides specialized AI tools for Biochemistry, Genetics and Molecular Biology researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Paper Summarizer
Get structured summaries of any paper in seconds
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Genetics and Neurodevelopmental Disorders with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Biochemistry, Genetics and Molecular Biology researchers